| Meghan Aileen Whitmarsh-brown, MD | |
|
3200 Broadmoor Blvd Ne, Rio Rancho, NM 87144-2105 | |
| (505) 994-7397 | |
| Not Available |
| Full Name | Meghan Aileen Whitmarsh-brown |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 8 Years |
| Location | 3200 Broadmoor Blvd Ne, Rio Rancho, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356704910 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unm Sandoval Regional Medical Center | Rio rancho, NM | Hospital |
| University Of New Mexico Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body's immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.
The American Dental Association (ADA) today commended the Federal agencies responsible for public health and safety for recalibrating the ratio of fluoride to water that they consider optimal based on scientific evaluation and the full appreciation of fluoride received from all sources.
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).
Politico: Problems in the nation's response to the current salmonella outbreak and the resulting recall of 600 million eggs is related to the Senate's year-long stall of pending food safety legislation, according to consumer groups and experts. "The House approved its version of the food safety bill in July 2009 — that was more than 60 recalls of Food and Drug Administration regulated products ago, according to a report by the Make Our Food Safe Coalition.
› Verified 9 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body's immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.
The American Dental Association (ADA) today commended the Federal agencies responsible for public health and safety for recalibrating the ratio of fluoride to water that they consider optimal based on scientific evaluation and the full appreciation of fluoride received from all sources.
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).
Politico: Problems in the nation's response to the current salmonella outbreak and the resulting recall of 600 million eggs is related to the Senate's year-long stall of pending food safety legislation, according to consumer groups and experts. "The House approved its version of the food safety bill in July 2009 — that was more than 60 recalls of Food and Drug Administration regulated products ago, according to a report by the Make Our Food Safe Coalition.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Aileen Whitmarsh-brown, MD 933 Bradbury Dr Se Ste 2222, Albuquerque, NM 87106-4375 Ph: (505) 272-1111 | Meghan Aileen Whitmarsh-brown, MD 3200 Broadmoor Blvd Ne, Rio Rancho, NM 87144-2105 Ph: (505) 994-7397 |
News Archive
New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body's immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.
The American Dental Association (ADA) today commended the Federal agencies responsible for public health and safety for recalibrating the ratio of fluoride to water that they consider optimal based on scientific evaluation and the full appreciation of fluoride received from all sources.
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).
Politico: Problems in the nation's response to the current salmonella outbreak and the resulting recall of 600 million eggs is related to the Senate's year-long stall of pending food safety legislation, according to consumer groups and experts. "The House approved its version of the food safety bill in July 2009 — that was more than 60 recalls of Food and Drug Administration regulated products ago, according to a report by the Make Our Food Safe Coalition.
› Verified 9 days ago
Derly Oscar Cuellar Iii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2400 Unser Blvd Se, Rio Rancho, NM 87124 Phone: 505-253-6100 | |
Nathan Elwood Huff, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 Unser Blvd Se Ste 08100, Rio Rancho, NM 87124 Phone: 505-253-6100 | |
Trevor Crean, D.O Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3200 Broadmoor Blvd Ne, Rio Rancho, NM 87144 Phone: 505-994-7397 | |
Matthew Morin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 Unser Blvd Se Ste 8100, Rio Rancho, NM 87124 Phone: 505-253-6100 | |
Franklin Guttmann, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4100 High Resort Blvd, Pmg High Resort 4100, Rio Rancho, NM 87124 Phone: 505-462-8800 Fax: 505-462-8898 | |
Dr. Shawn Mark Baker, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2400 Unser Blvd, Rio Rancho, NM 87124 Phone: 505-253-6100 |